Trisomy-9 in the bone marrow of a patient with acute myelomonoblastic leukaemia.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 4369401)

Published in Br J Haematol on March 01, 1974

Authors

F J Rutten, T W Hustinx, J M Scheres, D J Wagener

Articles citing this

Trisomy of chromosome 15 in spontaneous leukemia of AKR mice. Proc Natl Acad Sci U S A (1975) 1.84

Nonrandom chromosomal abnormalities in hematologic disorders of man. Proc Natl Acad Sci U S A (1975) 1.10

Articles by these authors

Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group. J Clin Oncol (1991) 3.25

A new chromosomal instability disorder: the Nijmegen breakage syndrome. Acta Paediatr Scand (1981) 2.16

Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma. J Clin Oncol (1998) 2.11

Habitual abortion and translocation (22q;22q): unexpected transmission from a mother to her phenotypically normal daughter. Clin Genet (1980) 1.76

Heritable fragile sites and lymphocyte culture medium containing BrdU. Am J Hum Genet (1980) 1.73

Hypersensitivity to ionizing radiation, in vitro, in a new chromosomal breakage disorder, the Nijmegen Breakage Syndrome. Mutat Res (1983) 1.46

Further delineation of the Nijmegen breakage syndrome. Am J Med Genet (1989) 1.35

Interruption of malaria transmission by chloroquinized salt in Guyana, with observations on a chloroquine-resistant strain of Plasmodium falciparum. Bull World Health Organ (1967) 1.25

Chromosome instability and X-ray hypersensitivity in a microcephalic and growth-retarded child. Am J Med Genet (1991) 1.24

Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study. Ann Oncol (2006) 1.11

Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group. J Clin Oncol (1996) 1.10

Identification of two Robertsonian translocations with a Giemsa banding technique. Humangenetik (1972) 1.09

The most common fragile site in man is 3p14. Hum Genet (1986) 1.09

Localization of haptoglobin and ABO. Nature (1965) 1.05

Prometaphase banding of human chromosomes with basic fuchsin. Hum Genet (1982) 0.98

Phase I and pharmacokinetic study of the orally administered farnesyl transferase inhibitor R115777 in patients with advanced solid tumors. Anticancer Drugs (2001) 0.95

Partial trisomy of chromosome 1 resulting from a complex maternal rearrangement of chromosomes 1, 5, and 6. Am J Med Genet (1979) 0.94

Chemotherapy of gastric cancer. Anticancer Drugs (1996) 0.94

Variegated aneuploidy related to premature centromere division (PCD) is expressed in vivo and is a cancer-prone disease. Am J Med Genet (2001) 0.94

Quantitative ultrasonic analysis of liver metastases. Ultrasound Med Biol (1998) 0.93

A mentally retarded child with a translocation involving chromosomes 12 and 19. J Med Genet (1975) 0.92

A presumptive tetrasomy for the short arm of chromosome 9. Humangenetik (1974) 0.92

Sperm analysis in a subfertile male with a Y;16 translocation, using four-color FISH. Cytogenet Cell Genet (1999) 0.92

The immunoglobulins in Hodgkin's disease. Eur J Cancer (1976) 0.91

Activity of cisplatin in adenocarcinoma of the pancreas. Eur J Cancer (1993) 0.91

Lipophilic analogues of sparsomycin as strong inhibitors of protein synthesis and tumor growth: a structure-activity relationship study. J Med Chem (1989) 0.90

Autosomal/heterosomal mixoploids: a report on two patients, a female with a 45, Z/47,XX plus 21 and a male with A 45,X/47,XY, plus 21 chromosome constitution. Ann Genet (1974) 0.89

Monocyte purification with counterflow centrifugation monitored by continuous flow cytometry. J Immunol Methods (1981) 0.88

Cimetidine does not influence immunological parameters in man. Clin Immunol Immunopathol (1981) 0.88

Connatal Pelizaeus-Merzbacher disease with congenital stridor in two maternal cousins. Acta Neuropathol (1981) 0.88

Concentration and sequence dependent synergism of ethyldeshydroxy-sparsomycin in combination with antitumor agents. Anticancer Drugs (1994) 0.87

The spleen in Hodgkin disease: diagnostic value of CT. Radiology (1985) 0.87

Evolutionary conservation of fragile sites induced by 5-azacytidine and 5-azadeoxycytidine in man, gorilla, and chimpanzee. Hum Genet (1985) 0.86

[Fasciola hepatica infection; an unusual cause of severe anemia]. Ned Tijdschr Geneeskd (1972) 0.85

Effect of carbogen breathing on the pharmacodynamics of 5-fluorouracil in a murine colon carcinoma. Eur J Cancer (2000) 0.85

Congenital adrenal hypoplasia, progressive muscular dystrophy, and severe mental retardation, in association with glycerol kinase deficiency, in male sibs. Clin Genet (1983) 0.85

Pancreatic carcinoma with polyarthritis, fat necrosis, and high serum lipase and trypsin activity. Gut (1990) 0.84

A familial syndrome of mental retardation in association with multiple congenital anomalies resembling the syndrome of Smith-Lemli-Opitz. Maandschr Kindergeneeskd (1967) 0.84

Subfertile men with constitutive chromosome abnormalities do not necessarily refrain from intracytoplasmic sperm injection treatment: a follow-up study on 75 Dutch patients. Hum Reprod (1999) 0.84

5-Fluorouracil metabolite patterns in viable and necrotic tumor areas of murine colon carcinoma determined by 19F NMR spectroscopy. Magn Reson Med (1996) 0.84

Simultaneous measurement, using flow cytometry, of radiosensitivity and defective mitogen response in ataxia telangiectasia and related syndromes. Eur J Pediatr (1992) 0.84

Cancer cachexia: what is known about its etiology and what should be the current treatment approach? Anticancer Res (2004) 0.83

Chromosome studies in IgA-deficient patients. Clin Genet (1987) 0.83

X-linked congenital hydrocephalus. Clin Neurol Neurosurg (1982) 0.83

Absence of Y-specific DNA sequences in human 46,XX true hermaphrodites and in 45,X mixed gonadal dysgenesis. Hum Genet (1987) 0.83

Karyotype instability with multiple 7/14 and 7/7 rearrangements. Hum Genet (1979) 0.83

Multicentre phase II pharmacological evaluation of rhizoxin. Eortc early clinical studies (ECSG)/pharmacology and molecular mechanisms (PAMM) groups. Br J Cancer (1996) 0.82

Significance of cell proliferation measurement in gastric cancer. Eur J Cancer (1998) 0.82

Immune responses in four patients with Bloom syndrome. Clin Immunol Immunopathol (1979) 0.82

Phase I and pharmacologic study of oral (PEG-1000) 9-aminocamptothecin in adult patients with solid tumors. J Clin Oncol (1999) 0.82

The influence of splenectomy on the invitro lymphocyte response to phytohemagglutinin and pokeweed mitogen in Hodgkin's disease. Cancer (1975) 0.82

Absence of Turner stigmata in a 46,XYp-female. Hum Genet (1992) 0.82

Effect of modulators on 5-fluorouracil metabolite patterns in murine colon carcinoma determined by in vitro 19F nuclear magnetic resonance spectroscopy. Cancer Res (1994) 0.81

Cell size, DNA, and cytokeratin analysis of human head and neck tumors by flow cytometry. Cytometry (1986) 0.81

Malignant histiocytosis. Clinical and cytogenetic studies in a newborn and a child. Cancer (1983) 0.81

Self-mutilation in a case of 49, XXXXY chromosomal constitution. J Ment Defic Res (1975) 0.81

Demonstration of X chromatin in drumstick-like nuclear appendages of leukocytes by in situ hybridization on blood smears. Histochemistry (1986) 0.81

Production of C and T bands in human chromosomes after heat treatment at high pH and staining with "stains-all". Humangenetik (1974) 0.81

Abnormal chromosome 18 in prenatal diagnosis with holoprosencephaly. Prenat Diagn (1997) 0.81

Hypothyroidism and goitre during interleukin-2 therapy without LAK cells. Lancet (1989) 0.81

Trisomy for the short arm of chromosome No. 10. Clin Genet (1974) 0.80

Advanced colorectal cancer, refractory to infusional fluorouracil treatment: efficacy of second line fluorouracil in combination with a different biochemical modulation. Anticancer Res (1997) 0.80

Immunological studies after long-term H2-receptor-antagonist therapy. Lancet (1977) 0.80

Letter: Bimodality in Hodgkin's disease. Lancet (1974) 0.80

Preclinical antitumor activity of ethyldeshydroxysparsomycin in combination with cisplatin. Invest New Drugs (1995) 0.80

"Incubation period" in Hodgkin's disease. Lancet (1975) 0.80

Precarious acrocentric short arm in prenatal diagnosis: no chromosome 14 polymorphism, but trisomy 17p. Genet Couns (2000) 0.80

Heterochromatin in the chromosomes of the gorilla: characterization with distamycin A/DAPI, D287/170, chromomycin A3, quinacrine, and 5-azacytidine. Cytogenet Cell Genet (1986) 0.80

Flow cytometric evaluation of cell dispersion from human head and neck tumors. Cytometry (1985) 0.79

Randomized neo-adjuvant chemotherapy trial for advanced head and neck cancer. Neth J Med (1985) 0.79

Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) in advanced gastric cancer. Cancer Chemother Pharmacol (1985) 0.79

A clinical pharmacokinetics study of carzelesin given by short-term intravenous infusion in a phase I study. Cancer Chemother Pharmacol (1998) 0.79

Altered intracellular enzyme activity of monocytes and lymphocytes in Hodgkin's disease. Eur J Cancer Clin Oncol (1983) 0.79

5-Fluorouracil in colorectal cancer: rationale and clinical results of frequently used schedules. Anticancer Drugs (1998) 0.78

alpha-Aminoadipic aciduria and persistence of fetal haemoglobin in an oligophrenic child. Eur J Pediatr (1981) 0.78

Characterization of a hormone-producing ovarian carcinoma cell line. Gynecol Oncol (1989) 0.78

The Martin-Bell syndrome: a psychological, logopaedic and cytogenetic study of two affected brothers. J Ment Defic Res (1983) 0.78

Bloom's syndrome in two Dutch families. Clin Genet (1977) 0.78

A case of partial 9p monosomy with some unusual clinical features. Ann Genet (1978) 0.78